STAY
INFORMED
Find our latest news and company updates. For all media inquiries, contact us at communications@sonicincytes.com.
Categories
May 4, 2023
Sonic Incytes Receives FDA 510(k) Clearance of AI Powered Features for Velacur™️ Liver...
Sonic Incytes is pleased to announce they have received Food and Drug Administration (FDA) clearance for new Organ Guide and...
Jan 18, 2023
Sonic Incytes Announces New Non-Dilutive Funding to Enhance Company’s Velacur™️ Medical Device
Sonic Incytes Medical Corp. is pleased to announce its project was selected for investment by the inaugural INOVAIT Focus Fund....
November 3, 2022
Sonic Incytes Announces Clinical Trial Data Comparing Velacur™️ and FibroScan®
Sonic Incytes Medical Corp. is pleased to announce clinical data from a prospective multi-center study comparing the effectiveness of Velacur™️...
June 13, 2022
Sonic Incytes Announces Velacur™️ use in Madrigal Pharmaceuticals’ Open-Label Extension Clinical Trial
Sonic Incytes Medical Corp. is pleased to announce the inclusion of Velacur™️ — the first handheld 3D liver health assessment tool—in...
May 24, 2022
Sonic Incytes Receives Award at 2022 Digestive Disease Week Conference
The poster entitled “Accuracy of Velacur™️ AI Powered Liver Guide in Identification of Liver” presented at the Digestive Disease Week...
March 29, 2022
Metabolic Syndrome: Myths, Assessment Tools, Novel Treatments and More
Metabolic syndrome is a cluster of conditions that increase the risk of many chronic illnesses such as heart disease, stroke,...
March 2, 2022
Register for Novel Tools for Managing Metabolic Syndrome
Sonic Incytes Medical Corp. is pleased to host a live educational webinar on Novel Tools for Managing Metabolic Syndrome. Metabolic...
February 3, 2022
Sonic Incytes Appoints New CEO and Chair to Accelerate Growth
Following the closing of its US$7.3M Series A raise in December 2021, the Sonic Incytes Medical Corp. Board of Directors...
December 7, 2021
Sonic Incytes Successfully Completes Series A Raise of US$7.3M to Accelerate VelacurTM Commercialization
Sonic Incytes Medical Corp., a health technology company focused on liver health, is pleased to announce the completion of its...
November 29, 2021
Learn about The Power of 3D Liver Ultrasound for NASH Clinical Trials
Join us virtually on December 1 at 10AMPT/12PM CT/1PM ET at the 5th Annual NASH Summit 2021 to learn about...
Get in Touch
Want to find out more?
